Guidesto Peptides

Is HGH Fragment 176-191 safe?

Unproven

Side effects, risks, and safety considerations based on available research.

Research status

HGH Fragment 176-191 lacks meaningful safety data. Claims about its safety are not well-supported by research. Using it means accepting unknown risks.

Known concerns & side effects

  • ⚠the unmodified fragment has not been studied in humans — nearly every human-relevant claim made about it is actually AOD-9604 trial data or animal-model data being extrapolated onto a different (less stable) molecule
  • ⚠AOD-9604 itself, despite being the properly-trialed, stabilized version, failed to beat placebo for weight loss in its pivotal Phase IIb trial (536 subjects), and the developer discontinued the obesity program in 2007
  • ⚠the raw 176-191 fragment is chemically less stable than AOD-9604 — it is more prone to degradation, which raises real questions about the potency and consistency of grey-market vials sold under this name
  • ⚠no published human pharmacokinetic or safety data exists for the unmodified fragment specifically, so dosing protocols circulating online are not derived from any clinical study
  • ⚠sold almost exclusively as an unregulated "research chemical," with no oversight of purity, concentration, or sterility
  • ⚠user reports across peptide communities skew toward no noticeable fat-loss effect, consistent with the thin evidence base rather than the marketing claims

Use caution with

treating this as interchangeable with AOD-9604 trial results — it is a different, less stable molecule with no human data of its ownexpecting meaningful fat loss — even the clinically-trialed, more stable version failed its pivotal human trialself-sourcing from unregulated research-chemical vendors for injectionconsult a physician before using any unregulated injectable peptide

Frequently asked questions

Is HGH Fragment 176-191 dangerous?

There is no published human safety or pharmacokinetic data on the unmodified fragment specifically, so a clear risk profile does not exist. The animal data and the limited AOD-9604 human data did not flag the growth-promoting or blood-sugar effects seen with full GH, which is a genuinely encouraging mechanistic finding. But that reassurance comes from a different, more stable molecule and from animal models — it should not be read as a safety guarantee for an unregulated, unstable research-chemical version sold for self-injection.

Is HGH Fragment 176-191 the same as AOD-9604?

No, though they are closely related and often confused. HGH Fragment 176-191 is the original, unmodified 16-amino-acid piece of human growth hormone identified by Monash University researchers. AOD-9604 is a further-modified, more chemically stable version of that same fragment, engineered specifically because the unmodified fragment degrades too easily to be a reliable drug candidate. AOD-9604, not the unmodified fragment, is the one that went into human clinical trials.

Does the human trial data for AOD-9604 apply to HGH Fragment 176-191?

Not directly. This is the single most important thing to understand about this peptide: the unmodified 176-191 fragment has not been studied in humans. Wikipedia's own entry on it notes it "has erroneously been presented as a lipolytic peptide fragment based on extrapolations of clinical data pertaining to AOD9604." Any claim you see that treats human AOD-9604 trial results as proof this fragment works is making an unsupported leap between two different molecules.

Did AOD-9604 even work in its human trials?

Not convincingly. An earlier, smaller trial showed a modest weight-loss signal versus placebo, but the pivotal, adequately powered Phase IIb trial (536 obese subjects, 24 weeks) failed to show statistically significant weight loss at any tested dose. Metabolic Pharmaceuticals discontinued the obesity development program in 2007. So even setting aside the fragment-vs-AOD-9604 confusion, the closest thing to real human evidence for this fat-burning mechanism did not hold up in its most rigorous test.

Why do sellers dose it at 250-500 mcg per day if there is no human data?

Those protocols are not derived from any published clinical study of this fragment — there isn't one. They appear to be extrapolated from AOD-9604 dosing ranges and general research-peptide community convention, not from dose-finding trials on the unmodified molecule itself.

Full HGH Fragment 176-191 Profile

Evidence, timeline, products & more

Take the Peptide Quiz

Get personalized recommendations

Last updated: 2026-09-10

Medical Disclaimer

The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.